0001949257 1 2026-09-09 2026-09-09 0001949257 2026-09-09 2026-09-09 iso4217:USD pure shares F-3 EX-FILING FEES 0001949257 N/A N/A F-3 Radiopharm Theranostics Limited false Equity Ordinary shares issuable upon exercise of warrants true 403718400 0.0069 2785656.96 0.0001381 384.70 2785656.96 384.70 0.00 0.00 384.70 In the form of American Depositary Shares (as evidenced by American Depositary Receipts, each representing 300 ordinary shares) have been registered on a separate registration statement on Form F-6 (File No. 333-282042). Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement includes an indeterminate number of additional shares that may be offered and sold to prevent dilution resulting from share splits, share dividends, recapitalizations or similar transactions. The maximum aggregate offering price has been estimated solely for the purpose of determining the amount of registration fee in accordance with Rule 457(c) under the Securities Act of 1933. The proposed maximum offering price per share and the proposed maximum aggregate offering price are based on the average of the high and low sale prices of the registrant’s ADSs on the Nasdaq Capital Market on September 9, 2026, or $2.08, divided by 300 (to give effect to the 300:1 ratio of ordinary shares to ADSs).